Case Study
Investor relations strategy design for a global pharma company
Client situation
A global pharmaceuticals company wanted to reassess its current investor relations strategy to better communicate to investors in complex situations
Project approach
After developing a first set of hypotheses, SDI assessed 60 top performing IR Companies internationally to define actionable implications to achieve IR Excellence
Outcome
SDI identified concrete improvement opportunities for IR clustered in distribution, product, marketing, and internal structure